A. Scaramelli

841 total citations
21 papers, 613 citations indexed

About

A. Scaramelli is a scholar working on Psychiatry and Mental health, Genetics and Neurology. According to data from OpenAlex, A. Scaramelli has authored 21 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Genetics and 6 papers in Neurology. Recurrent topics in A. Scaramelli's work include Epilepsy research and treatment (10 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). A. Scaramelli is often cited by papers focused on Epilepsy research and treatment (10 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). A. Scaramelli collaborates with scholars based in Uruguay, Germany and Austria. A. Scaramelli's co-authors include Diéter Janz, C Chouza, Karen Weissbecker, R S Sparkes, M. Durner, M. Anne Spence, Edwin Walker, J. D’Souza, Gérard Flesch and Christian E. Elger and has published in prestigious journals such as The Lancet, Epilepsia and Clinical Pharmacokinetics.

In The Last Decade

A. Scaramelli

21 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Scaramelli Uruguay	10	416	236	189	142	115	21	613
Jan‐Peter Ernst Germany	5	463 1.1×	271 1.1×	237 1.3×	65 0.5×	134 1.2×	6	555
Masakazu Seino Japan	17	651 1.6×	384 1.6×	362 1.9×	72 0.5×	117 1.0×	98	839
Barbara Steinborn Poland	15	303 0.7×	201 0.9×	177 0.9×	63 0.4×	164 1.4×	74	650
Alfredo D’Aniello Italy	15	356 0.9×	208 0.9×	155 0.8×	99 0.7×	82 0.7×	44	647
Santiago Galicchio Argentina	6	445 1.1×	259 1.1×	201 1.1×	165 1.2×	83 0.7×	22	664
B. Tonnby Sweden	10	305 0.7×	265 1.1×	89 0.5×	105 0.7×	66 0.6×	13	480
Marina Nikanorova Denmark	16	734 1.8×	535 2.3×	364 1.9×	139 1.0×	93 0.8×	29	943
F. J. Ritter United States	6	715 1.7×	493 2.1×	247 1.3×	41 0.3×	53 0.5×	11	804
Jason Coryell United States	10	247 0.6×	160 0.7×	139 0.7×	89 0.6×	172 1.5×	13	532
Xiu‐Yu Shi China	15	369 0.9×	143 0.6×	219 1.2×	234 1.6×	283 2.5×	57	731

Countries citing papers authored by A. Scaramelli

Since Specialization

Citations

This map shows the geographic impact of A. Scaramelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Scaramelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Scaramelli more than expected).

Fields of papers citing papers by A. Scaramelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Scaramelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Scaramelli. The network helps show where A. Scaramelli may publish in the future.

Co-authorship network of co-authors of A. Scaramelli

This figure shows the co-authorship network connecting the top 25 collaborators of A. Scaramelli. A scholar is included among the top collaborators of A. Scaramelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Scaramelli. A. Scaramelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Damián, Andrés, et al.. (2021). SPECT activation patterns in psychogenic non-epileptic seizures in temporal lobe epilepsy patients. Seizure. 90. 110–116. 4 indexed citations

2.

Braga, Patrícia, et al.. (2019). Applicability and contribution of the new ILAE 2017 classification of epileptic seizures and epilepsies∗. Epileptic Disorders. 21(6). 549–554. 8 indexed citations

3.

Fagiolino, Pietro, et al.. (2011). Influence of Efflux Transporters on Drug Metabolism. Clinical Pharmacokinetics. 50(2). 75–80. 12 indexed citations

4.

Sander, T., Rebekka Kretz, Magali Williamson, et al.. (2009). Linkage analysis between idiopathic generalized epilepsies and the GABAA receptor α5, β3 and γ3 subunit gene cluster on chromosome 15. Acta Neurologica Scandinavica. 96(1). 1–7. 4 indexed citations

5.

Scaramelli, A., et al.. (2008). Prodromal symptoms in epileptic patients: Clinical characterization of the pre-ictal phase. Seizure. 18(4). 246–250. 62 indexed citations

6.

Chouza, C, et al.. (2006). Thirty five years of experience in the treatment of Parkinson’s disease with levodopa and associations. PubMed. 427–431. 1 indexed citations

7.

Anderson, Eric C., Samuel F. Berkovic, Olivier Dulac, et al.. (2002). ILAE Genetics Commission Conference Report: Molecular Analysis of Complex Genetic Epilepsies. Epilepsia. 43(10). 1262–1267. 17 indexed citations

8.

Berkovic, Samuel F., Mogens Laue Friis, Dick Lindhout, et al.. (2002). ILAE Genetics Commission Conference Report: Molecular Analysis of Complex Genetic Epilepsies. Epilepsia. 43(12). 1600–1602. 7 indexed citations

9.

Walker, Edwin, Christian E. Elger, A. Scaramelli, et al.. (2000). Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy. Epilepsia. 41(12). 1597–1607. 175 indexed citations

10.

Sander, Thomas, Herbert Schulz, Amedeo Bianchi, et al.. (1999). Evaluation of a putative major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q14. American Journal of Medical Genetics. 88(2). 182–187. 3 indexed citations

11.

Sander, Thomas, Herbert Schulz, Amedeo Bianchi, et al.. (1999). Evaluation of a putative major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q14. American Journal of Medical Genetics. 88(2). 182–187. 16 indexed citations

12.

Sander, Thomas, Rebekka Kretz, Herbert Schulz, et al.. (1998). Replication Analysis of a Putative Susceptibility Locus (EGI) for Idiopathic Generalized Epilepsy on Chromosome 8q24. Epilepsia. 39(7). 715–720. 13 indexed citations

13.

Scaramelli, A., et al.. (1997). 1-17-25 Prevalence of epilepsies in a population of Uruguay: Study of “Villa del Cerro”. Journal of the Neurological Sciences. 150. S29–S29. 1 indexed citations

14.

Sander, Thomas, Thomas Hildmann, Diéter Janz, et al.. (1996). Exclusion of linkage between idiopathic generalized epilepsies and the GABAA receptor α1 and γ2 subunit gene cluster on chromosome 5. Epilepsy Research. 23(3). 235–244. 9 indexed citations

15.

Scaramelli, A., Maria Caceres, C. LʼHéritier, et al.. (1991). Double‐Blind, Placebo‐Controlled, Cross‐Over Trial of Progabide as Add‐On Therapy in Epileptic Patients. Epilepsia. 32(1). 133–139. 3 indexed citations

16.

Weissbecker, Karen, M. Durner, Diéter Janz, et al.. (1991). Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6. American Journal of Medical Genetics. 38(1). 32–36. 129 indexed citations

17.

Chouza, C, et al.. (1990). Long-term treatment with Madopar HBS in parkinsonians with fluctuations.. PubMed. 53. 519–26. 4 indexed citations

18.

Chouza, C, et al.. (1989). Combination of selegiline and controlled release levodopa in the treatment of fluctuations of clinical disability in parkinsonian patients. Acta Neurologica Scandinavica. 80. 127–137. 13 indexed citations

19.

Chouza, C, et al.. (1988). A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson’s disease. PubMed. 27. 61–70. 2 indexed citations

20.

Chouza, C, et al.. (1986). PARKINSONISM, TARDIVE DYSKINESIA, AKATHISIA, AND DEPRESSION INDUCED BY FLUNARIZINE. The Lancet. 327(8493). 1303–1304. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact